Bair Teresa Brophy — SEC insider filings

SEC reporting owner CIK 1813058. 20 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2020-08-07 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kura Oncology, Inc. (KURA)Chief Legal Officer17—15 legs · 95,211 sh · $1,036,44811
Athenex, Inc. (ATNX)General Counsel, SVP Admin.3——4

Insider filings — Bair Teresa Brophy

FiledFormIssuerReported transactionsSource
2026-11-184Kura Oncology, Inc. (KURA)Sale (S): 8,601 @ $7.44EDGAR
2026-09-294Kura Oncology, Inc. (KURA)Sale (S): 8,442 @ $10.50EDGAR
2026-08-214Kura Oncology, Inc. (KURA)Sale (S): 31,487 @ $12.63EDGAR
2026-05-204Kura Oncology, Inc. (KURA)Sale (S): 2,256 @ $9.38EDGAR
2026-01-274Kura Oncology, Inc. (KURA)Sale (S): 4,096 @ $8.46 · Sale (S): 2,335 @ $8.46 · Sale (S): 4,777 @ $8.46EDGAR
2026-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-11-144Kura Oncology, Inc. (KURA)Grant/award (A): 48,900 @ $0 · Sale (S): 8,804 @ $11.18EDGAR
2025-09-294Kura Oncology, Inc. (KURA)Grant/award (A): 48,900 @ $0 · Sale (S): 8,805 @ $8.94EDGAR
2025-05-194Kura Oncology, Inc. (KURA)Sale (S): 1,559 @ $5.96EDGAR
2025-01-284Kura Oncology, Inc. (KURA)Sale (S): 2,437 @ $7.87 · Sale (S): 4,844 @ $7.87EDGAR
2025-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 46,250 @ $0 · Grant/award (A): 92,500 (derivative) @ $0EDGAR
2024-05-204Kura Oncology, Inc. (KURA)Sale (S): 2,615 @ $22.15EDGAR
2024-01-314Kura Oncology, Inc. (KURA)Sale (S): 2,053 @ $17.80EDGAR
2024-01-044Kura Oncology, Inc. (KURA)Grant/award (A): 46,250 @ $0 · Grant/award (A): 92,500 (derivative) @ $0EDGAR
2023-02-214Kura Oncology, Inc. (KURA)Grant/award (A): 23,125 @ $0 · Grant/award (A): 138,750 (derivative) @ $0EDGAR
2022-11-184Kura Oncology, Inc. (KURA)Sale (S): 2,100 @ $15.22EDGAR
2021-10-194Kura Oncology, Inc. (KURA)Grant/award (A): 192,000 (derivative) @ $0EDGAR
2021-08-054Athenex, Inc. (ATNX)Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2020-08-314Athenex, Inc. (ATNX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2020-08-074Athenex, Inc. (ATNX)Grant/award (A): 60,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1813058 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs